1. Home
  2. DGII vs CDNA Comparison

DGII vs CDNA Comparison

Compare DGII & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digi International Inc.

DGII

Digi International Inc.

HOLD

Current Price

$44.15

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGII
CDNA
Founded
1985
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.0B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
DGII
CDNA
Price
$44.15
$19.15
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$46.80
$26.67
AVG Volume (30 Days)
295.4K
768.6K
Earning Date
02-04-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
77.05
N/A
EPS
1.08
1.22
Revenue
$430,221,000.00
$357,998,000.00
Revenue This Year
$10.51
$14.11
Revenue Next Year
$8.01
$11.75
P/E Ratio
$41.19
$16.03
Revenue Growth
1.46
14.46
52 Week Low
$22.39
$10.96
52 Week High
$48.00
$25.95

Technical Indicators

Market Signals
Indicator
DGII
CDNA
Relative Strength Index (RSI) 56.44 54.88
Support Level $43.60 $19.01
Resistance Level $44.59 $20.61
Average True Range (ATR) 1.23 0.80
MACD -0.34 -0.15
Stochastic Oscillator 18.64 25.75

Price Performance

Historical Comparison
DGII
CDNA

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: